Eastman Chemical Company (EMN) Stock

Eastman Chemical Company trades at a P/E ratio of 9.71, which is below the market average of approximately 20. This lower valuation could indicate the market has modest growth expectations, or it might represent an undervalued opportunity if the fundamentals are strong. Looking ahead, the forward P/E of 10.44 is higher than the current P/E, indicating analysts expect earnings to decline over the next year. The PEG ratio of 1.93 indicates reasonable value when growth is considered.

With a beta of 1.26, Eastman Chemical Company is roughly as volatile as the market, moving in line with broad market trends. This moderate beta suggests the stock offers market-level returns without excessive volatility. The price-to-book ratio of 1.50 shows investors value the company above its book value, which often reflects intangible assets or growth prospects.

Eastman Chemical Company achieves a profit margin of 9.85%, meaning it retains $9.85 from every $100 in revenue after all expenses. This represents a solid margin typical of well-run businesses, showing the company can effectively balance revenue generation with cost control. The operating margin of 13.90% reveals how efficiently the company runs its core business operations before interest and taxes. With ROE at 16.00% and ROA at 5.95%, the company generates strong returns on invested capital.

Eastman Chemical Company's revenue declined by 0.90% year-over-year, indicating challenges in maintaining sales momentum. This contraction may reflect market headwinds, competitive pressures, or strategic transitions. Earnings increased by 13.00% year-over-year, outpacing revenue growth through improved margins. These growth metrics should be evaluated against PLASTIC MATERIALS, SYNTH RESINS & NONVULCAN ELASTOMERS industry averages for proper context.

Eastman Chemical Company offers a dividend yield of 4.36%, paying $3.28 per share annually. This high yield exceeds 4%, significantly outperforming the S&P 500 average of 1.5-2% and most investment-grade bonds. For income-focused investors, this represents an attractive cash flow opportunity, though high yields sometimes signal market concerns about sustainability. To receive the next dividend, shares must be purchased before the ex-dividend date of 6/13/2025.

The dividend sustainability can be assessed through the payout ratio - Eastman Chemical Company pays $3.28 per share in dividends against earnings of $7.85 per share, resulting in a payout ratio of 41.78%. This balanced payout between 30-60% suggests a sustainable dividend policy that allows both shareholder returns and business reinvestment. The dividend appears well-covered by earnings. The next dividend payment is scheduled for 7/8/2025.

Eastman Chemical Company has a market capitalization of $8.80B, classifying it as a mid-cap stock ($2B-$10B). Mid-caps often represent companies in their growth phase, offering higher growth potential than large-caps but with more stability than small-caps. They can be attractive takeover targets and may become tomorrow's large-caps. With 115.46M shares outstanding, the company's ownership is relatively concentrated. As a participant in the PLASTIC MATERIALS, SYNTH RESINS & NONVULCAN ELASTOMERS industry, it competes with other firms in this sector.

Eastman Chemical Company's book value per share is $50.87, while the current stock price is $78.33, resulting in a price-to-book (P/B) ratio of 1.54. This reasonable premium to book value suggests the market values the company's earnings power and intangible assets appropriately. Most profitable companies trade between 1-3x book value. As a common stock, this represents equity ownership with voting rights.

19 analysts cover EMN with 68% recommending buy/strong buy ratings. Analyst predictions have mixed reliability - studies show consensus rarely beats market returns consistently. The mixed views reflect uncertainty about the outlook. The consensus target of $97.67 implies 24.7% upside, but targets are often adjusted to follow price moves rather than predict them.

Current analyst recommendations:3 Strong Buy, 10 Buy, 6 Hold, 00The bullish tilt suggests optimism about future prospects, though investors should conduct independent research.Remember that analyst opinions often lag price movements and can be influenced by investment banking relationships.

RSI data is not available for this stock.

MACD and moving average data are not available for this stock.